Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gayathri Rajaraman has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ZOOMED IN, ZONED OUT: Academic Self-Reports on the Challenges and Benefits of Online Teaching in Higher Education

    by Gayathri Rajaraman, Rudi Klein, Puspha Sinnayah

    Online teaching in higher education has become increasingly prevalent, especially in light of the COVID-19 pandemic. While teaching online offers many benefits, it also presents several challenges. Sharing one’s lived experiences as an educator is essential to improving one’s teaching skills and enhancing the learning outcomes for the students. Here, we present our personal and lived experiences as higher education teachers in the VU Block Model® First Year College at Victoria University. In our allied health science subjects, we have identified the key challenges in online teaching, such as technology and infrastructure, student engagement and interaction, adapting learning styles, assessment integrity, digital literacy, social-isolation-related mental health, and workload. The benefits included flexibility, innovative teaching tools, personalised learning and accessibility, and the continuity of teaching and learning despite the pandemic disruption. Overcoming these challenges requires careful planning, effective pedagogy, and ongoing support for both teachers and students. The benefits of online teaching can be maximised when its limitations are acknowledged and addressed appropriately via sharing teacher’s personal narratives as an effective mode of communication.


  • Open Access

    Decreased Placental FPR2 in Early Pregnancies That Later Developed Small-For-Gestation Age: A Potential Role of FPR2 in the Regulation of Epithelial-Mesenchymal Transition

    by Padma Murthi, Gayathri Rajaraman, Jan Jaap H.M. Erwich, Evdokia Dimitriadis

    We reported earlier that an anti-inflammatory small peptide receptor-formyl peptide receptor-2 (FPR2) was significantly decreased in placentas from third trimester pregnancies complicated with fetal growth restriction (FGR), compared to placentas from uncomplicated control pregnancies, suggesting FPR2 may play a role in the development of FGR. The aim of this study is to investigate whether the actions of FPR2 alters placental growth process in humans. Accordingly, using small-for-gestation age (SGA) as a proxy for FGR, we hypothesize that FPR2 expression is decreased in first-trimester placentas of women who later manifest FGR, and contributes to aberrant trophoblast function and the development of FGR. Chorionic villus sampling (CVS) tissues were collected at 10–12 weeks gestation in 70 patients with singleton fetuses; surplus tissue was used. Real-time PCR and immunoassays were performed to quantitate FPR2 gene and protein expression. Silencing of FPR2 was performed in two independent, trophoblast-derived cell lines, HTR-8/SVneo and JEG-3 to investigate the functional consequences of FPR2 gene downregulation. FPR2 mRNA relative to 18S rRNA was significantly decreased in placentae from SGA-pregnancies (n = 28) compared with controls (n = 52) (p < 0.0001). Placental FPR2 protein was significantly decreased in SGA compared with control (n = 10 in each group, p < 0.05). Proliferative, migratory and invasive potential of the human placental-derived cell lines, HTR-8/SVneo and JEG-3 were significantly reduced in siFPR2 treated cells compared with siCONT control groups. Down-stream signaling molecules, STAT5B and SOCS3 were identified as target genes of FPR2 action in the trophoblast-derived cell lines and in SGA and control chorionic villous tissues. FPR2 is a novel regulator of key molecular pathways and functions in placental development, and its decreased expression in women destined to develop FGR reinforces a placental origin of SGA/FGR, and that it contributes to causing the development of SGA/FGR.


  • Expression of Homeobox Gene HLX and its Downstream Target Genes are Altered in Placentae From Discordant Twin Pregnancies

    by Nicola Yuen, Shaun P. Brennecke, Mark P. Umstad, Hannah E. J. Yong, Anthony J. Borg, Gayathri Rajaraman, Bill Kalionis, Padma Murthi

    A discordant twin gestation, in which one fetus is significantly growth restricted, compared to the other normal twin, is a unique model that can be used to elucidate the mechanism(s) by which the intrauterine environment affects fetal growth. In many model systems, placental transcription factor genes regulate fetal growth. Transcription factors regulate growth through their activation or repression of downstream target genes that mediate important cell functions. The objective of this study was to determine the expression of the placental HLX homeobox gene transcription factor and its downstream target genes in dizygotic twins with growth discordance. In this cross-sectional study, HLX and its downstream target genes’ retinoblastoma 1 (RB1) and cyclin kinase D (CDKN1C) expression levels were determined in placentae obtained from dichorionic diamniotic twin pregnancies (n = 23) where one of the twins was growth restricted. Fetal growth restriction (FGR) was defined as small for gestational age with abnormal umbilical artery Doppler indices when compared with the normal control co-twin. Homeobox gene HLX expression was significantly decreased at both the mRNA and protein levels in FGR twin placentae compared with the normal control co-twin placentae (p < .05). Downstream target genes CDKN1C and RB1 were also significantly decreased and increased, respectively, at both the mRNA and protein levels in FGR twin placentae compared with normal control co-twin placentae (p < .05). Together, these observations suggest an important association between HLX transcription factor expression and abnormal human placental development in discordant twin pregnancies.


  • G protein coupled receptor 18: A potential role for endocannabinoid signaling in metabolic dysfunction

    by Gayathri Rajaraman, Anna Simcocks, Deanne H. Hryciw, Dana S. Hutchinson, Andrew J. McAinch

    Endocannabinoids are products of dietary fatty acids that are modulated by an alteration in food intake levels. Overweight and obese individuals have substantially higher circulating levels of the arachidonic acid‐derived endocannabinoids, anandamide and 2‐arachidonoyl glycerol, and show an altered pattern of cannabinoid receptor expression. These cannabinoid receptors are part of a large family of G protein‐coupled receptors (GPCRs). GPCRs are major therapeutic targets for various diseases within the cardiovascular, neurological, gastrointestinal and endocrine systems, as well as metabolic disorders such as obesity and type 2 diabetes mellitus. Obesity is considered a state of chronic low grade inflammation elicited by an immunological response. Interestingly, the newly deorphanised G protein‐coupled receptor GPR18, which is considered to be a putative cannabinoid receptor, is proposed to have an immunological function. In this review, the current scientific knowledge on GPR18 is explored including its localisation, signalling pathways and pharmacology. Importantly, the involvement of nutritional factors and potential dietary regulation of GPR18 and its (patho)physiological roles are described. Further research on this receptor and its regulation will enable a better understanding of the complex mechanisms of GPR18 and its potential as a novel therapeutic target for treating metabolic disorders. This article is protected by copyright. All rights reserved


  • Homeobox genes and down-stream transcription factor PPARγ in normal and pathological human placental development

    by P. Murthi, B. Kalionis, M. Cocquebert, G. Rajaraman, A. Chui, R.J. Keogh, D. Evain-Brion, T. Fournier


  • Optimization and Scale-up Culture of Human Endometrial Multipotent Mesenchymal Stromal Cells: Potential for Clinical Application

    by Gayathri Rajaraman, Jacinta White, Ker Sin Tan, Daniela Ulrich, Anna Rosamilia, Jerome Werkmeister, Caroline E. Gargett

    We have previously identified and purified multipotent mesenchymal stromal cell (MSC)-like cells in the highly regenerative endometrial lining of the human uterus (eMSC) as CD140b⁺CD146⁺ cells. Due to ease of accessibility with minimal morbidity via biopsy, we are proposing to use eMSC in cell-based therapies; however, culture conditions compliant with Good Manufacturing Practice have not been established for eMSC. The aim of this study was to optimize serum-free and xeno-free culture conditions for expansion of eMSC for potential clinical use. Real-time cell assessment (Xcelligence) and MTS viability assays were used to measure attachment and proliferation of freshly isolated, flow cytometry-sorted CD140b⁺CD146⁺ eMSC cultured in several commercially available and in-house serum-free and xeno-free media in combination with five attachment matrices (fibronectin, collagen, gelatin, laminin, and Cell Start-XF®). Comparisons were made with a standard serum-containing medium, DMEM/F-12/10% fetal bovine serum. Under all conditions examined, eMSC attachment and proliferation was greatest using a fibronectin matrix, with Lonza TP-SF® and our in-house DMEM/SF/FGF2/EGF serum-free xeno-product-containing medium similar to serum-containing medium. Hypoxia increased eMSC proliferation in the DMEM/SF/FGF2/EGF serum-free medium. Culture of eMSC for 7 days on a fibronectin matrix in DMEM/SF/FGF2/EGF serum-free media in 5% O₂ maintained greater numbers of undifferentiated eMSC expressing CD140b, CD146, and W5C5 compared to culture under similar conditions in Lonza TP-SF medium. However, the percentage of cells expressing typical MSC phenotypic markers, CD29, CD44, CD73, and CD105, were similar for both media. EMSC showed greater expansion in 2D compared to 3D culture on fibronectin-coated microbeads using the optimized DMEM/SF/FGF2/EGF medium in 5% O₂. In the optimized 2D culture conditions, eMSC retained CFU activity, multipotency, and MSC surface phenotype, representing the first steps in their preparation for potential clinical use.


  • The Role of Homeobox Genes in the Development of Placental Insufficiency

    by Padma Murthi, Bill Kalionis, Gayathri Rajaraman, Rosemary J. Keogh, Fabricio Da Silva Costa

    Intrauterine growth restriction (IUGR) is an adverse pregnancy outcome associated with significant perinatal and pediatric morbidity and mortality, and an increased risk of chronic disease later in adult life. While a number of maternal, fetal and environmental factors are known causes of IUGR, the majority of IUGR cases are of unknown cause. These IUGR cases are frequently associated with placental insufficiency, possibly as a result of placental maldevelopment. Understanding the molecular mechanisms of abnormal placental development in IUGR associated with placental insufficiency is therefore of increasing importance. Here, we review our understanding of transcriptional control of normal placental development as well as human IUGR associated with placental insufficiency. We also assess the potential for understanding transcriptional control as a means for revealing new molecular targets for the detection, diagnosis and clinical management of IUGR associated with placental insufficiency.


  • Placental Syndecan Expression Is Altered in Human Idiopathic Fetal Growth Restriction

    by Amy Chui, Nurul Zainuddin, Gayathri Rajaraman, Padma Murthi, Shaun P. Brennecke, Vera Ignjatovic, Paul T. Monagle, Joanne M. Said


  • Open Access

    The Role of Placental Homeobox Genes in Human Fetal Growth Restriction

    by Padma Murthi, Gayathri Rajaraman, Shaun Patrick Brennecke, Bill Kalionis

    Fetal growth restriction (FGR) is an adverse pregnancy outcome associated with significant perinatal and paediatric morbidity and mortality, and an increased risk of chronic disease later in adult life. One of the key causes of adverse pregnancy outcome is fetal growth restriction (FGR). While a number of maternal, fetal, and environmental factors are known causes of FGR, the majority of FGR cases remain idiopathic. These idiopathic FGR pregnancies are frequently associated with placental insufficiency, possibly as a result of placental maldevelopment. Understanding the molecular mechanisms of abnormal placental development in idiopathic FGR is, therefore, of increasing importance. Here, we review our understanding of transcriptional control of normal placental development and abnormal placental development associated with human idiopathic FGR. We also assess the potential for understanding transcriptional control as a means for revealing new molecular targets for the detection, diagnosis, and clinical management of idiopathic FGR.


  • Homeobox Gene HLX Is a Regulator of HGF/c-met-Mediated Migration of Human Trophoblast-Derived Cell Lines1

    by Gayathri Rajaraman, Padma Murthi, Shaun P. Brennecke, Bill Kalionis

    Homeobox gene transcription factors play a critical role in normal placental development and are expressed in specialized trophoblast cells. Abnormal trophoblast function is associated with clinically significant pregnancy disorders, including fetal growth restriction (FGR). Our previous studies demonstrated that homeobox gene HLX is expressed in proliferating and migrating (but not invading) human trophoblast cells and that HLX expression is significantly decreased in human FGR. We have also shown that HLX is a regulator of colony-stimulating-factor-1-dependent trophoblast proliferation. Hepatocyte growth factor (HGF) activates trophoblast cell migration in a paracrine fashion, and its receptor, c-met, is expressed on trophoblast cells. Given that HGF is a regulator of trophoblast migration, we hypothesize that HLX is a mediator of HGF/c-met-dependent trophoblast migration but not invasion. Here we investigated the potential role of HLX in HGF/c-met-mediated trophoblast migration and invasion in two human trophoblast-derived cell lines, SGHPL-4 and HTR-8/SVneo. Results showed that in cultured trophoblast cells, HGF stimulation significantly increased HLX mRNA and protein expression. HLX inactivation significantly decreased trophoblast migration but not invasion. When HLX was inactivated in the presence of HGF stimulation, migration remained significantly decreased. SU11274-mediated inhibition of the receptor c-met significantly decreased HLX mRNA and protein expression. In the presence of HGF stimulation, HLX expression remained significantly decreased with c-met inhibition. This is the first study to show that homeobox gene HLX is a downstream effector gene of HGF, that HLX regulates human trophoblast-derived cell migration, and that HGF, via receptor c-met, acts through HLX to control cell migration.